Operating margin moved 119 bp higher
Operating margin changed +119 basis points from the comparable as-filed period.
9.69%→10.88%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →DRS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Gross margin moved 155 bp higher
Gross margin changed +155 basis points from the comparable as-filed period.
23.13%→24.67%2 prior comparisons
Operating cash flow decreased 10.3%
Operating cash flow changed -10.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$107.0M→$96.0M2 prior comparisons
Operating cash flow / net income decreased 43.8%
Operating cash flow / net income changed -43.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
1.49→0.832 prior comparisons
Revenue increased 11.0%
Revenue changed +11.0% from the comparable as-filed period.
$960.0M→$1.1B2 prior comparisons
Debt / revenue moved 1848 bp lower
Debt / revenue changed -1848 basis points from the comparable as-filed period.
33.96%→15.48%2 prior comparisons
Free-cash-flow margin moved 258 bp lower
Free-cash-flow margin changed -258 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
8.02%→5.44%2 prior comparisons
Capital expenditure increased 26.7%
Capital expenditure changed +26.7% from the comparable as-filed period.
$30.0M→$38.0M2 prior comparisons
Operating cash-flow margin moved 214 bp lower
Operating cash-flow margin changed -214 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
11.15%→9.01%2 prior comparisons
Gross profit increased 18.5%
Gross profit changed +18.5% from the comparable as-filed period.
$222.0M→$263.0M2 prior comparisons
Working capital / assets moved 217 bp lower
Working capital / assets changed -217 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
25.54%→23.37%4 prior comparisons
Stock-based compensation increased 20.0%
Stock-based compensation changed +20.0% from the comparable as-filed period.
$5.0M→$6.0M2 prior comparisons
Cost of revenue increased 8.8%
Cost of revenue changed +8.8% from the comparable as-filed period.
$738.0M→$803.0M2 prior comparisons
Capex / revenue moved 44 bp higher
Capex / revenue changed +44 basis points from the comparable as-filed period.
3.13%→3.56%2 prior comparisons
Current liabilities increased 6.9%
Current liabilities changed +6.9% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.1B→$1.2B4 prior comparisons
Total assets increased 3.0%
Total assets changed +3.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$4.2B→$4.4B4 prior comparisons
Trade receivables increased 9.5%
Trade receivables changed +9.5% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$327.0M→$358.0M4 prior comparisons
Shares outstanding increased 0.2%
Shares outstanding changed +0.2% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes.
266,026,725→266,621,0858 prior comparisons
Inventory decreased 7.4%
Inventory changed -7.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$404.0M→$374.0M4 prior comparisons
Cash & equivalents decreased 4.9%
Cash & equivalents changed -4.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$309.0M→$294.0M4 prior comparisons
Working capital decreased 5.7%
Working capital changed -5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.1B→$1.0B4 prior comparisons
SBC / revenue moved 4 bp higher
SBC / revenue changed +4 basis points from the comparable as-filed period.
0.52%→0.56%2 prior comparisons
Research & development increased 2.8%
Research & development changed +2.8% from the comparable as-filed period.
$36.0M→$37.0M2 prior comparisons
Receivables / revenue moved 48 bp lower
Receivables / revenue changed -48 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
34.06%→33.58%2 prior comparisons
Current ratio decreased 5.9%
Current ratio changed -5.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
2→1.884 prior comparisons
Current assets increased 0.6%
Current assets changed +0.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$2.2B→$2.2B4 prior comparisons
R&D / revenue moved 28 bp lower
R&D / revenue changed -28 basis points from the comparable as-filed period.
3.75%→3.47%2 prior comparisons
Free-cash-flow proxy changed across a sign change
Free-cash-flow proxy changed +110.7% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$56.0M→$6.0M3 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +225.0% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$28.0M→$35.0M3 prior comparisons
Revenue increased 10.1%
Revenue changed +10.1% from the comparable as-filed period.
$829.0M→$913.0M2 prior comparisons
Free-cash-flow margin moved 741 bp higher
Free-cash-flow margin changed +741 basis points from the comparable as-filed period.
-6.76%→0.66%2 prior comparisons
Debt / revenue moved 2470 bp lower
Debt / revenue changed -2470 basis points from the comparable as-filed period.
39.93%→15.22%2 prior comparisons
Operating cash-flow margin moved 721 bp higher
Operating cash-flow margin changed +721 basis points from the comparable as-filed period.
-3.38%→3.83%2 prior comparisons
Receivables / revenue moved 297 bp higher
Receivables / revenue changed +297 basis points from the comparable as-filed period.
31.97%→34.94%2 prior comparisons
Working capital / assets moved 293 bp lower
Working capital / assets changed -293 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
26.16%→23.23%4 prior comparisons
Trade receivables increased 20.4%
Trade receivables changed +20.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$265.0M→$319.0M4 prior comparisons
Research & development increased 20.0%
Research & development changed +20.0% from the comparable as-filed period.
$30.0M→$36.0M2 prior comparisons
Gross profit increased 20.3%
Gross profit changed +20.3% from the comparable as-filed period.
$197.0M→$237.0M2 prior comparisons
Working capital decreased 8.6%
Working capital changed -8.6% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$1.1B→$975.0M4 prior comparisons
Capex / revenue moved 20 bp lower
Capex / revenue changed -20 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
3.38%→3.18%2 prior comparisons
Total assets increased 2.9%
Total assets changed +2.9% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$4.1B→$4.2B4 prior comparisons
Shares outstanding increased 0.3%
Shares outstanding changed +0.3% from the comparable as-filed period. The change ranks at the 25th percentile of 8 prior comparable changes.
266,123,634→266,891,5158 prior comparisons
Cost of revenue increased 7.0%
Cost of revenue changed +7.0% from the comparable as-filed period.
$632.0M→$676.0M2 prior comparisons
Stock-based compensation increased 16.7%
Stock-based compensation changed +16.7% from the comparable as-filed period.
$6.0M→$7.0M3 prior comparisons
Inventory decreased 4.2%
Inventory changed -4.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$400.0M→$383.0M4 prior comparisons
SBC / revenue moved 4 bp higher
SBC / revenue changed +4 basis points from the comparable as-filed period.
0.72%→0.77%2 prior comparisons
Operating cash flow / net income changed across a sign change
Operating cash flow / net income changed +178.5% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-0.52→0.412 prior comparisons
Cash & equivalents decreased 2.9%
Cash & equivalents changed -2.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$278.0M→$270.0M4 prior comparisons
R&D / revenue moved 32 bp higher
R&D / revenue changed +32 basis points from the comparable as-filed period.
3.62%→3.94%2 prior comparisons
Current assets increased 0.7%
Current assets changed +0.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$2.0B→$2.0B4 prior comparisons
Capital expenditure increased 3.6%
Capital expenditure changed +3.6% from the comparable as-filed period.
$28.0M→$29.0M3 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.